Nucleic Acids Research, 1989, Vol. 17, No. 7 2655-2674
© 1989
MOLECULAR BIOLOGY |
Evidence for nuclear factors involved in recognition of 5' splice sites
Verna and Marrs McClean Department of Biochemistry, Baylor College of Medicine One Baylor Plaza, Houston, TX 77030. USA
Received December 14, 1988. Revised February 22, 1989. Accepted February 22, 1989.
To investigate soluble factors involved in pre-messenger RNA splicing we have fractionated nuclear extract by simple centrifugation to produce a supernatant pellet pair. Factors larger than 15S including U2, U4, U5, and U6 snRNPs fractionate with the pellet; U1 snRNPs distribute equally in pellet and supernatant. Each fraction is individually incompetent for splicing and spliceosome assembly; mixing restores wild type activity and assembly. The pellet fraction directs an aberrant assembly pathway in which proper 3', but improper 5' splice site recognition occurs. Complexes formed with the pellet fraction are distinguishable from wild-type complexes using native gel electrophoresis. Pellet complexes contain U1 snRNP antigens and their formation requires ATP, U1 snRNPs, U2 snRNPs, and sequences at the 3' end of the intron - properties shared with the initial steps of normal assembly and directed by sequences at the 3' end of the intron. In contrast, pellet complex assembly shows no dependence on the presence of a 5' splice junction within precursor RNA. Furthermore, binding of factors to the 5' splice junction is deficient in pellet assemblies. Thus, the pellet lacks a factor required for proper recognition of 5' splice sites. This factor can be supplied by the supernatant. Complementation occurs when supernatant U1 RNA is destroyed, suggesting that the supernatant factor recognizing 5' splice sites is not U1 snRNPs.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Bohne, H. Wodrich, and H.-G. Kräusslich Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end Nucleic Acids Res., February 8, 2005; 33(3): 825 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Singh, J Valcarcel, and M. Green Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins Science, May 26, 1995; 268(5214): 1173 - 1176. [Abstract] [PDF]
|
|
|
|
 |
|
 C W Siebel, L D Fresco, and D C Rio The mechanism of somatic inhibition of Drosophila P-element pre-mRNA splicing: multiprotein complexes at an exon pseudo-5' splice site control U1 snRNP binding. Genes & Dev., August 1, 1992; 6(8): 1386 - 1401. [Abstract] [PDF]
|
|
|
|
|
|
A Gil, P A Sharp, S F Jamison, and M A Garcia-Blanco Characterization of cDNAs encoding the polypyrimidine tract-binding protein. Genes & Dev., July 1, 1991; 5(7): 1224 - 1236. [Abstract] [PDF]
|
|
|
|
|
|
A R Krainer, G C Conway, and D Kozak Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes & Dev., July 1, 1990; 4(7): 1158 - 1171. [Abstract] [PDF]
|
|
|
|
|
|
C. Siebel and D. Rio Regulated splicing of the Drosophila P transposable element third intron in vitro: somatic repression Science, June 8, 1990; 248(4960): 1200 - 1208. [Abstract] [PDF]
|
|
|
|
|
|
V Heinrichs, M Bach, G Winkelmann, and R Luhrmann U1-specific protein C needed for efficient complex formation of U1 snRNP with a 5' splice site Science, January 5, 1990; 247(4938): 69 - 72. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Guth and a. J. Valcarcel Kinetic Role for Mammalian SF1/BBP in Spliceosome Assembly and Function after Polypyrimidine Tract Recognition by U2AF J. Biol. Chem., November 22, 2000; 275(48): 38059 - 38066. [Abstract] [Full Text] [PDF]
|
|